Abstract
BACKGROUND: Women with polycystic ovary syndrome (PCOS) have been reported to have subclinical cardiovascular disease (CVD) and increased abdominal fat. The aim of this study was to evaluate the relationship between visceral fat (VF) and early markers of CVD in PCOS women. METHODS: Two hundred overweight PCOS women [(mean ± SD) age 24.6 ± 3.2 years, body mass index (BMI) 28.5 ± 2.8 kg/m2] and 100 healthy age- and BMI-matched volunteer controls entered this cross-sectional study. In all subjects, the amount of VF was measured by ultrasonography. Anthropometric measurements [BMI and waist circumference (WC)], complete hormonal and metabolic pattern, carotid intima-media thickness (IMT), brachial arterial flow-mediated dilation (FMD) and inflammatory biomarkers [C-reactive protein (CRP), fibrinogen, white blood cells count and plasminogen activated inhibitor-1] were also obtained from all subjects. A stepwise linear regression model was used in PCOS patients to verify if IMT or FMD as dependent variables are affected by other independent variables. RESULTS: VF amount was significantly (P <0.001) higher in PCOS subjects than in healthy controls [31.4 ± 7.3 versus 28.0 ± 6.1 (mean±SD) mm, respectively] and directly related to insulin resistance: HOMA (r = 0.918, P <0.001) and AUCINS (r = 0.879, P <0.001), and to WC (r = 0.658; P <0.001). In PCOS, the two linear regression analyses showed that IMT is positively affected by VF and CRP, whereas FMD is positively affected by IMT and negatively by VF and CRP. CONCLUSIONS: VF amount is associated with subclinical CVD in PCOS patients.
| Original language | English |
|---|---|
| Pages (from-to) | 153-159 |
| Number of pages | 7 |
| Journal | Human Reproduction |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2008 |
Fingerprint
Keywords
- Cardiovascular risk
- Hyperandrogenism
- Insulin resistance
- PCOS
- Visceral fat
ASJC Scopus subject areas
- Physiology
- Developmental Biology
- Obstetrics and Gynaecology
- Reproductive Medicine
- Medicine(all)
Cite this
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. / Cascella, Teresa; Palomba, Stefano; De Sio, Ilario; Manguso, Francesco; Giallauria, Francesco; De Simone, Biagio; Tafuri, Domenico; Lombardi, Gaetano; Colao, Annamaria; Orio, Francesco.
In: Human Reproduction, Vol. 23, No. 1, 01.2008, p. 153-159.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
AU - Cascella, Teresa
AU - Palomba, Stefano
AU - De Sio, Ilario
AU - Manguso, Francesco
AU - Giallauria, Francesco
AU - De Simone, Biagio
AU - Tafuri, Domenico
AU - Lombardi, Gaetano
AU - Colao, Annamaria
AU - Orio, Francesco
PY - 2008/1
Y1 - 2008/1
N2 - BACKGROUND: Women with polycystic ovary syndrome (PCOS) have been reported to have subclinical cardiovascular disease (CVD) and increased abdominal fat. The aim of this study was to evaluate the relationship between visceral fat (VF) and early markers of CVD in PCOS women. METHODS: Two hundred overweight PCOS women [(mean ± SD) age 24.6 ± 3.2 years, body mass index (BMI) 28.5 ± 2.8 kg/m2] and 100 healthy age- and BMI-matched volunteer controls entered this cross-sectional study. In all subjects, the amount of VF was measured by ultrasonography. Anthropometric measurements [BMI and waist circumference (WC)], complete hormonal and metabolic pattern, carotid intima-media thickness (IMT), brachial arterial flow-mediated dilation (FMD) and inflammatory biomarkers [C-reactive protein (CRP), fibrinogen, white blood cells count and plasminogen activated inhibitor-1] were also obtained from all subjects. A stepwise linear regression model was used in PCOS patients to verify if IMT or FMD as dependent variables are affected by other independent variables. RESULTS: VF amount was significantly (P <0.001) higher in PCOS subjects than in healthy controls [31.4 ± 7.3 versus 28.0 ± 6.1 (mean±SD) mm, respectively] and directly related to insulin resistance: HOMA (r = 0.918, P <0.001) and AUCINS (r = 0.879, P <0.001), and to WC (r = 0.658; P <0.001). In PCOS, the two linear regression analyses showed that IMT is positively affected by VF and CRP, whereas FMD is positively affected by IMT and negatively by VF and CRP. CONCLUSIONS: VF amount is associated with subclinical CVD in PCOS patients.
AB - BACKGROUND: Women with polycystic ovary syndrome (PCOS) have been reported to have subclinical cardiovascular disease (CVD) and increased abdominal fat. The aim of this study was to evaluate the relationship between visceral fat (VF) and early markers of CVD in PCOS women. METHODS: Two hundred overweight PCOS women [(mean ± SD) age 24.6 ± 3.2 years, body mass index (BMI) 28.5 ± 2.8 kg/m2] and 100 healthy age- and BMI-matched volunteer controls entered this cross-sectional study. In all subjects, the amount of VF was measured by ultrasonography. Anthropometric measurements [BMI and waist circumference (WC)], complete hormonal and metabolic pattern, carotid intima-media thickness (IMT), brachial arterial flow-mediated dilation (FMD) and inflammatory biomarkers [C-reactive protein (CRP), fibrinogen, white blood cells count and plasminogen activated inhibitor-1] were also obtained from all subjects. A stepwise linear regression model was used in PCOS patients to verify if IMT or FMD as dependent variables are affected by other independent variables. RESULTS: VF amount was significantly (P <0.001) higher in PCOS subjects than in healthy controls [31.4 ± 7.3 versus 28.0 ± 6.1 (mean±SD) mm, respectively] and directly related to insulin resistance: HOMA (r = 0.918, P <0.001) and AUCINS (r = 0.879, P <0.001), and to WC (r = 0.658; P <0.001). In PCOS, the two linear regression analyses showed that IMT is positively affected by VF and CRP, whereas FMD is positively affected by IMT and negatively by VF and CRP. CONCLUSIONS: VF amount is associated with subclinical CVD in PCOS patients.
KW - Cardiovascular risk
KW - Hyperandrogenism
KW - Insulin resistance
KW - PCOS
KW - Visceral fat
UR - http://www.scopus.com/inward/record.url?scp=40549136010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40549136010&partnerID=8YFLogxK
U2 - 10.1093/humrep/dem356
DO - 10.1093/humrep/dem356
M3 - Article
C2 - 18024952
AN - SCOPUS:40549136010
VL - 23
SP - 153
EP - 159
JO - Human Reproduction
JF - Human Reproduction
SN - 0268-1161
IS - 1
ER -